Kirsten E. Peters
6 Verdun Street
Perth, WA 6009, Australia
Perth, WA 6009, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Economic Impact of PromarkerD In Vitro Diagnostic Testing on the Management of Chronic Kidney Disease in Type 2 Diabetes: A Budget Impact Analysis.
Journal: PharmacoEconomics - open
Published: October 30, 2025
Prognostic value of a plasma protein-based biomarker test for chronic kidney disease complicating diabetes in Aboriginal Australians.
Journal: Internal medicine journal
Published: August 04, 2025
A Clinical Validation of a Diagnostic Test for Esophageal Adenocarcinoma Based on a Novel Serum Glycoprotein Biomarker Panel: PromarkerEso.
Journal: Proteomes
Published: April 03, 2025
Assessment of biomarkers associated with renal decline for prediction of incident distal sensory polyneuropathy in type 2 diabetes.
Journal: Scientific reports
Published: March 17, 2025
Analytical and Clinical Performance of a Novel Immunoassay-Based Test System to Predict Diabetic Kidney Disease.
Journal: The journal of applied laboratory medicine
Published: February 24, 2025
Evaluating the potential clinical practice impact of the PromarkerD blood test in people with type 2 diabetes in Australia.
Journal: Internal medicine journal
Published: February 11, 2025
PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes.
Journal: Diagnostics (Basel, Switzerland)
Published: February 06, 2025
Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: the Fremantle Diabetes Study Phase II.
Journal: Clinical diabetes and endocrinology
Published: May 08, 2024
Use of a type 1 genetic risk score for classification of diabetes type in young Australian adults: the Fremantle Diabetes Study Phase II.
Journal: Internal medicine journal
Published: November 28, 2023
Serum vitamin B12, distal symmetrical polyneuropathy and anaemia in type 2 diabetes: the Fremantle Diabetes Study Phase 2.
Journal: Internal medicine journal
Published: July 17, 2023
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores.
Journal: Journal of clinical medicine
Published: February 28, 2023
The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II.
Journal: Acta diabetologica
Published: July 05, 2022
Last Updated: 09/26/2026